Shanghai-based Zhongshan Hospital, affiliated with Fudan University, where many of the Chinese experts leading global liver ...

Cash and cash equivalents at €122.1 million and €24.6 million in short-term deposits2 as of June 30, 2025Revenues of €4.5 ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Cancer rates are on the rise worldwide, and liver cancer is the sixth most common cause of the disease, according to the ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Six of every 10 liver cancers diagnosed globally are preventable through reduction of risk factors, a “conservative calculation” of cases projected until 2050 has concluded.1 The Lancet commission on ...

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver ...

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of ...

Obesity-related liver disease cases have been climbing most rapidly across the United States, Europe and Asia, the study found ...

IT often strikes without symptoms until it’s too late – but spotting the early red flags of liver cancer could save your life ...

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alc ...